News
7h
Zacks.com on MSNCan Eylea HD and Dupixent Profits Revive Regeneron Stock?
Detailed price information for Bayer Aktienges ADR (BAYRY) from The Globe and Mail including charting and trades.
11h
Clinical Trials Arena on MSNCytomX to continue Phase I ADC trial despite patient death
CytomX's Phase I trial of ADC CX-2051 in colorectal cancer will continue based on a decision made by a safety committee ...
Harrow's Q2 results show promise, but high debt, market challenges, and execution risks loom. Read here for strategies to ...
Cary Street Partners Financial LLC dramatically reduced its stake in Regeneron Pharmaceuticals. The firm now holds a mere 255 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results